Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Dianthus Therapeutics, Inc.(DNTH) | 1,841,667 | 1,686,667 | -155,000 | $179.53M | $148.51M | 20.07% | -$31.01M |
| ABIVAX Société AnonymeADS(ABVX) | 993,000 | 993,000 | 0 | $132.33M | $98.33M | 13.29% | -$34.00M |
| Definium Therapeutics, Inc.(DFTX) | 2,950,000 | 2,511,000 | -439,000 | $138.77M | $95.57M | 12.91% | -$43.20M |
| Cogent Biosciences, Inc.(COGT) | 2,350,000 | 2,350,000 | 0 | $90.94M | $75.25M | 10.17% | -$15.70M |
| ArriVent BioPharma, Inc.(AVBP) | 1,971,054 | 2,141,387 | +170,333 | $68.47M | $64.84M | 8.76% | -$3.63M |
| Taysha Gene Therapies, Inc.(TSHA) | 9,693,244 | 9,693,244 | 0 | $66.01M | $47.21M | 6.38% | -$18.80M |
| Obsidian Therapeutics Inc | 0 | 2,414,610 | +2,414,610 | $0 | $33.15M | 4.48% | +$33.15M |
| Kymera Therapeutics, Inc.(KYMR) | 310,000 | 205,000 | -105,000 | $35.55M | $22.92M | 3.10% | -$12.63M |
| Disc Medicine, Inc.(IRON) | 270,000 | 270,000 | 0 | $19.75M | $17.67M | 2.39% | -$2.07M |
| Tango Therapeutics, Inc.(TNGX) | 0 | 630,000 | +630,000 | $0 | $15.72M | 2.12% | +$15.72M |
| Xenon Pharmaceuticals Inc.(XENE) | 490,000 | 420,000 | -70,000 | $29.58M | $15.62M | 2.11% | -$13.96M |
| Adlai Nortye Group Ltd.ADS(ANL) | 934,716 | 934,716 | 0 | $10.75M | $14.96M | 2.02% | +$4.21M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 338,900 | 169,450 | -169,450 | $39.68M | $14.48M | 1.96% | -$25.19M |
| Aktis Oncology, Inc.(AKTS) | 960,847 | 713,000 | -247,847 | $30.97M | $13.88M | 1.88% | -$17.09M |
| Palisade Bio, Inc.(PALI) | 10,276,317 | 10,276,317 | 0 | $21.48M | $13.87M | 1.87% | -$7.60M |
| BioAge Labs, Inc.(BIOA) | 1,748,000 | 1,300,000 | -448,000 | $42.84M | $9.22M | 1.25% | -$33.63M |
| Pharvaris N V COM | 456,721 | 249,000 | -207,721 | $15.79M | $7.90M | 1.07% | -$7.90M |
| Gyre Therapeutics, Inc.(GYRE) | 954,416 | 954,416 | 0 | $6.29M | $7.00M | 0.95% | +$706.3K |
| DBV Technologies S.A.ADS(DBVT) | 574,200 | 574,200 | 0 | $9.42M | $6.75M | 0.91% | -$2.66M |
| Ocular Therapeutix, Inc.(OCUL) | 2,075,000 | 599,900 | -1,475,100 | $20.38M | $4.60M | 0.62% | -$15.78M |
| Trevi Therapeutics, Inc.(TRVI) | 315,000 | 315,000 | 0 | $5.87M | $4.51M | 0.61% | -$1.36M |
| Faeth Therapeutics, Inc.(FTH) | 361,010 | 100,000 | -261,010 | $9.03M | $2.97M | 0.40% | -$6.05M |
| Precision BioSciences, Inc.(DTIL) | 1,350,000 | 430,000 | -920,000 | $10.61M | $2.69M | 0.36% | -$7.92M |
| Unicycive Therapeutics, Inc.(UNCY) | 1,000,000 | 275,000 | -725,000 | $4.69M | $1.29M | 0.17% | -$3.40M |
| Gossamer Bio, Inc.(GOSS) | 7,750,000 | 96,875 | -7,653,125 | $1.28M | $1.15M | 0.16% | -$127.7K |
| Alumis Inc | 2,830,700 | 0 | -2,830,700 | $79.66M | $0 | — | -$79.66M |
| Context Therapeutics Inc.(CNTX) | 3,050,000 | 0 | -3,050,000 | $1.69M | $0 | — | -$1.69M |
| Summit Therapeutics Inc.(SMMT) | 1,250,000 | 0 | -1,250,000 | $18.21M | $0 | — | -$18.21M |